Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
11/2005
11/02/2005CN1691948A Adsorbent for oral administration
11/02/2005CN1691941A Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment
11/02/2005CN1689585A Arsenic-containing pharmaceutical composition for treating skin metastatic carcinoma combined with radiotherapy
11/02/2005CN1689584A Compound preparation for treating gynecological disease
11/02/2005CN1689576A Magnetic slow release 5-aminosalicylic acid with intercalate structure and its preparation method
11/01/2005US6960596 Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer
11/01/2005US6960358 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
11/01/2005US6960249 Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface
10/2005
10/29/2005CA2503331A1 Lubricious ophthalmic solutions
10/27/2005WO2005101019A2 Detection of nitrosylated proteins
10/27/2005WO2005099821A1 Use of simethicone in constipated patients
10/27/2005WO2005099765A1 Liquid composition and process for producing the same
10/27/2005WO2005099658A2 Compositions for oral hygiene and method for using same
10/27/2005WO2005034728A3 Colon cleansing composition and method
10/27/2005WO2004073648A3 Composition and methods for inhibiting cell survival
10/27/2005US20050239900 Use of low molecular weight amino alcohols in ophthalmic compositions
10/27/2005US20050239765 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer
10/27/2005US20050239763 Non-GMO metal amino acid chelates and non-GMO metal amino acid chelate-containing compositions
10/27/2005US20050238739 Composition comprising a combination of calcium, cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
10/27/2005US20050238734 Detection of nitrosylated proteins
10/27/2005US20050238733 Topical anesthesia of the urinary bladder
10/27/2005US20050238731 Composition and method for treating the effects of diseases and maladies of the upper digestive tract
10/27/2005US20050238729 biosynthesis inhibition via formaldehyde, glutaraldehyde, acrolein, quaternary amine compounds, cocodiamine, bronopol, 2-2-dibromo-3-nitrilo-propionamide; synergistic; cost efficiency
10/27/2005US20050238728 Synergistic topically applied personal hygiene product
10/27/2005US20050238727 Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer
10/27/2005US20050238726 N-methyl D-aspartic acid (NMDA) receptor antagonism; neuroprotection
10/27/2005US20050238638 Dietary Supplement that Serves as a Carbohydrate Blocker and Hangover Remedy
10/27/2005US20050238635 Use of hyrogen peroxide producting enzyme for treatment of otitis media
10/27/2005US20050238600 Method for using zinc oxide hair lotion
10/27/2005CA2503554A1 Dietary supplement
10/26/2005EP1588739A1 Composition comprising a combination of calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
10/26/2005EP1588710A1 Anti-allergic composition and method for denaturing allergens
10/26/2005EP1588629A1 Matrix-forming composition containing pectin
10/26/2005EP1587522A1 Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
10/26/2005EP1587484A2 Method of treating angiogenic tissue growth
10/26/2005EP1587481A2 Sensitive proteasome sensor constructs and methods for their design and use
10/26/2005EP1444264A4 Methods and materials for targeting and affecting selected cells
10/26/2005CN1688330A Method for cancer therapy using herbal extracts
10/26/2005CN1688322A Antiseptic solutions containing silver chelated with polypectate and EDTA
10/26/2005CN1688303A Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
10/26/2005CN1688300A Peritoneal dialysate containing taurine
10/26/2005CN1686549A Medicinal composition for treating high blood pressure
10/26/2005CN1686547A Long time use compound preparation for treating diabetes
10/26/2005CN1686165A Medical nano-carbon tube composition, preparation method and its application
10/26/2005CN1686164A Treparation method of medicine for treating thyreoidism, scrofula and hypodermic tumour and application
10/26/2005CN1686163A Medicine for treating oral cavity ulcer
10/26/2005CN1686162A Trielement ion anti virus composition and its application
10/26/2005CN1686161A Medicine for treating recurring toothache and its preparation method
10/26/2005CN1686160A Medicinal preparation for supplementing calcium magnesium
10/26/2005CN1224479C Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod
10/26/2005CN1224399C Medicinal Compsition for treating verrucosis
10/26/2005CN1224388C Modified prodrug forms of ap/amp
10/26/2005CN1224385C Medicament contg. platinum complex compounds and use thereof
10/25/2005US6958359 administering vanadium cyclopentadienyl complexes; vandocene acetylacetonate; preventing diabetic retinopathy, hemangiomas, cancers with abnormal blood vessel supply, restenosis following vascular injury; antitumor, antiproliferative agents
10/25/2005US6958163 Antioxidants in clusters of structured water
10/25/2005US6958159 Pharmaceutical gel composition
10/20/2005WO2005098024A1 In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes
10/20/2005WO2005097885A2 Precipitation of additives in over-saturated triblock copolymer elastomers
10/20/2005WO2005097216A1 Compositions containing copper salts and soy products
10/20/2005WO2005097211A2 Compositions as adjuvants to improve immune responses to vaccines and methods of use
10/20/2005WO2005097195A2 Methods of reducing aggregation of il-1ra
10/20/2005WO2005097144A1 Composition for cleaning intestinal canal
10/20/2005WO2005097143A1 Eye drops consisting of filtered clayey water for treating glaucoma
10/20/2005WO2005097138A2 Combinations comprising oxcarbazepine to treat affective disorders
10/20/2005WO2005097085A1 Nutrient system for individualized responsive dosing regimens
10/20/2005WO2005097084A2 Calcium salts for the treatment of psoriasis, dermatitis and dandruff
10/20/2005WO2005097078A1 Compressed composition comprising magnesium salt
10/20/2005WO2005097045A1 Healthcare and cosmetic compositions containing nanodiamond
10/20/2005WO2005096846A1 Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
10/20/2005WO2005096840A1 Kiwifruit extracts and extraction methods
10/20/2005US20050233947 Combinations of chromium or vanadium with antidiabetics
10/20/2005US20050233946 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
10/20/2005US20050233341 Using single nucleotide polymorphism in fucose-1-phosphate guanylyltransferase (FPGT) and cyclin dependent kinase kinesin genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference
10/20/2005US20050233010 mood-stabilizing lithium citrate or lithium carbonate with other psychoactive drug; antidepressant, anxiolytic agent; psychological, bipolar disorder, schizophrenia; synergistic mixture; time release; combination reduces suidical tendencies
10/20/2005US20050233008 Comprehensive pharmacologic therapy for treatment of a dysfunction
10/20/2005US20050233007 Materials and methods of using calcium for reduction of inflammation
10/20/2005US20050233005 Use of glycosaminoglycans and zinc derivatives for insect bites, stings and the like
10/20/2005US20050232999 Method for producing a chitosan containing salt having a function of lowering blood pressure
10/20/2005US20050232989 Process for preparing oral calcium compositions
10/20/2005US20050232955 Cosmetic compositions containing small magnetic particles
10/20/2005US20050232901 Materials and methods for treating or preventing oxalate-related disease
10/20/2005US20050232895 Anti-viral pharmaceutical compositions
10/20/2005US20050232868 In situ administering into nasal cavities; mixture of flow control agents and deactivating compound
10/20/2005US20050231646 Circuit for processing video signal including information such as caption
10/20/2005CA2592845A1 Eye drops consisting of filtered clayey water for treating glaucoma
10/20/2005CA2561856A1 Compressed composition comprising magnesium salt
10/20/2005CA2560941A1 Compositions as adjuvants to improve immune responses to vaccines and methods of use
10/19/2005EP1586336A1 Compositions containing copper salts and soy products
10/19/2005EP1586312A1 Agent for dissolving dental calculi and dental caries
10/19/2005EP1492879A4 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
10/19/2005EP1339415A4 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
10/19/2005EP1202728B1 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins.
10/19/2005EP1100541B1 Hydrogel for the therapeutic treatment of aneurysms
10/19/2005CN1684696A Oral and dental composition
10/19/2005CN1682960A Gujinsa capsule and its preparing process
10/19/2005CN1682861A Composite medicine for treating diabetes
10/19/2005CN1682761A Hemostatic agent and its preparing method
10/19/2005CN1682760A Multiple micro element for injection and preparing method
10/19/2005CN1682759A Health article useful for preventing and treating cardiovascular diseases
10/19/2005CN1682758A Aluminium sulfate for injection and aluminium sulfate injection for treating bladder tumor
1 ... 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 ... 563